Will Intellia Therapeutics (NASDAQ:NTLA) Spend Its Cash Wisely?

Simply Wall St12/16 18:42

Why Intellia Therapeutics (NTLA) Is the Worst ARK Stock to Buy According to Short Sellers

Yahoo Finance12/12 00:57

Lilly Tops Morgan Stanley's Biopharma Pick List for 2025

Seeking Alpha12/07 05:21

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire12/04 05:01

Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?

Benzinga11/27 11:37

NTLA Up as FDA Grants RMAT Status to Genome-Editing Therapy

Zacks 11/26 23:05